Accession Number:

ADA443050

Title:

The Mechanism of Tetinoblastoma Protein-Mediated Terminal Cell Cycle Arrest

Descriptive Note:

Annual summary rept. 1 Sep 2004-31 Aug 2005

Corporate Author:

DANA-FARBER CANCER INST BOSTON MA

Personal Author(s):

Report Date:

2005-09-01

Pagination or Media Count:

29.0

Abstract:

A prognostic feature of many human cancers is a high mitotic index and the inability to maintain a terminal cell cycle arrest TCCA. The Rb gene product retinoblastoma protein has been implicated in the maintenance of a terminal cell cycle arrest. Likewise the inactivation of retinoblastoma gene Rb is observed in several human cancers including those of the breast. However, in contrast to our knowledge of how pRb regulates proliferation in a cycling population, little is known how it maintains a permanent cell cycle arrest. The proposed study was aimed at elucidating the molecular mechanism by which pRb accomplishes this task and plays the role of tumor suppressor of tumor formation. Our working hypothesis was that pRb in cooperation with basic helix loop helix bHLH protein MyoD participates in the transcriptional repression of one or more immediate early genes required for the induction of cyclin Dl. And this event ultimately prevents the reentry into the cell cycle, thus maintaining a terminal cell cycle arrest. To test this hypothesis myogenic differentiation has been used as model, because it represents a differentiation system in which pRb has been implicated in a terminal cell cycle arrest both in vitro and in vivo. In this study I have established that, among various immediate early genes only the induction of Fra-1 is blocked in pRb and myoD dependent manner leading to cyclin Dl control and is independent of the cell cycle inhibitory protein pl 6. Whereas an ectopic expression of Fra-1 by adenovirus-vector which leads to induction of cyclin Dl in identical settings confirmed a causal relationship between Fra-1 expression and cyclin Dl. Further a biochemical analysis of the Fra-1 gene regulation using wild type promoter reporter LUC and a mutant for MyoD binding constructs confirmed the loss of MyoD binding to the promoter renders its ability to inhibit the Fra-1 induction.

Subject Categories:

  • Anatomy and Physiology

Distribution Statement:

APPROVED FOR PUBLIC RELEASE